RU2245709C2 - Применение аналогов сибутрамина для профилактики сахарного диабета - Google Patents

Применение аналогов сибутрамина для профилактики сахарного диабета Download PDF

Info

Publication number
RU2245709C2
RU2245709C2 RU99108468/14A RU99108468A RU2245709C2 RU 2245709 C2 RU2245709 C2 RU 2245709C2 RU 99108468/14 A RU99108468/14 A RU 99108468/14A RU 99108468 A RU99108468 A RU 99108468A RU 2245709 C2 RU2245709 C2 RU 2245709C2
Authority
RU
Russia
Prior art keywords
insulin
formula
compound
person
diabetes mellitus
Prior art date
Application number
RU99108468/14A
Other languages
English (en)
Russian (ru)
Other versions
RU99108468A (ru
Inventor
Клиффорд Джеймс БЭЙЛИ (GB)
Клиффорд Джеймс БЭЙЛИ
Роберт Брайн ДЖОНС (GB)
Роберт Брайн ДЖОНС
Хелен Кристин ДЖЕКСОН (GB)
Хелен Кристин ДЖЕКСОН
Original Assignee
Кнолль Акциенгезелльшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Кнолль Акциенгезелльшафт filed Critical Кнолль Акциенгезелльшафт
Publication of RU99108468A publication Critical patent/RU99108468A/ru
Application granted granted Critical
Publication of RU2245709C2 publication Critical patent/RU2245709C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Electrotherapy Devices (AREA)
RU99108468/14A 1996-09-21 1997-09-15 Применение аналогов сибутрамина для профилактики сахарного диабета RU2245709C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9619757.9A GB9619757D0 (en) 1996-09-21 1996-09-21 Chemical process
GB9619757.9 1996-09-21

Publications (2)

Publication Number Publication Date
RU99108468A RU99108468A (ru) 2001-02-20
RU2245709C2 true RU2245709C2 (ru) 2005-02-10

Family

ID=10800326

Family Applications (1)

Application Number Title Priority Date Filing Date
RU99108468/14A RU2245709C2 (ru) 1996-09-21 1997-09-15 Применение аналогов сибутрамина для профилактики сахарного диабета

Country Status (26)

Country Link
US (3) US6174925B1 (cg-RX-API-DMAC10.html)
EP (1) EP0927028A1 (cg-RX-API-DMAC10.html)
JP (1) JP2001503737A (cg-RX-API-DMAC10.html)
KR (1) KR20000048501A (cg-RX-API-DMAC10.html)
CN (1) CN1237905A (cg-RX-API-DMAC10.html)
AU (1) AU724488B2 (cg-RX-API-DMAC10.html)
BG (1) BG64473B1 (cg-RX-API-DMAC10.html)
BR (1) BR9711517A (cg-RX-API-DMAC10.html)
CA (1) CA2266401C (cg-RX-API-DMAC10.html)
CZ (1) CZ93699A3 (cg-RX-API-DMAC10.html)
GB (1) GB9619757D0 (cg-RX-API-DMAC10.html)
HR (1) HRP970505A2 (cg-RX-API-DMAC10.html)
HU (1) HUP9904026A3 (cg-RX-API-DMAC10.html)
ID (1) ID18320A (cg-RX-API-DMAC10.html)
IL (1) IL128850A (cg-RX-API-DMAC10.html)
MY (1) MY116150A (cg-RX-API-DMAC10.html)
NO (1) NO991358L (cg-RX-API-DMAC10.html)
NZ (1) NZ334580A (cg-RX-API-DMAC10.html)
PL (1) PL332305A1 (cg-RX-API-DMAC10.html)
RU (1) RU2245709C2 (cg-RX-API-DMAC10.html)
SK (1) SK31999A3 (cg-RX-API-DMAC10.html)
TR (1) TR199900618T2 (cg-RX-API-DMAC10.html)
TW (1) TW580385B (cg-RX-API-DMAC10.html)
UA (1) UA64726C2 (cg-RX-API-DMAC10.html)
WO (1) WO1998011884A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA978450B (cg-RX-API-DMAC10.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2430913C2 (ru) * 2006-01-06 2011-10-10 Сепракор Инк. Циклоалкиламины в качестве ингибиторов повторного поглощения моноамина
RU2832377C1 (ru) * 2024-01-09 2024-12-23 Владимир Анатольевич Пуценко Способ первичной профилактики сахарного диабета первого типа с применением внутритканевого электрофореза поджелудочной железы с профилактическими препаратами

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9619757D0 (en) * 1996-09-21 1996-11-06 Knoll Ag Chemical process
JP2000080047A (ja) * 1998-06-30 2000-03-21 Takeda Chem Ind Ltd 医 薬
EP1093370B1 (en) * 1998-06-30 2006-02-22 Takeda Pharmaceutical Company Limited Pharmaceutical composition for the treatment of diabetes
US6476078B2 (en) 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6974838B2 (en) 1998-08-24 2005-12-13 Sepracor Inc. Methods of treating or preventing pain using sibutramine metabolites
US6331571B1 (en) 1998-08-24 2001-12-18 Sepracor, Inc. Methods of treating and preventing attention deficit disorders
US6339106B1 (en) 1999-08-11 2002-01-15 Sepracor, Inc. Methods and compositions for the treatment and prevention of sexual dysfunction
DZ2937A1 (fr) * 1998-11-12 2004-03-15 Smithkline Beecham Plc Compositions nouvelles de sensibilidants à l'insuline.
US20040102486A1 (en) * 1998-11-12 2004-05-27 Smithkline Beecham Corporation Novel method of treatment
WO2000028989A1 (en) * 1998-11-12 2000-05-25 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
US6323242B1 (en) 1998-12-02 2001-11-27 Peter Sterling Mueller Treatment of disorders secondary to organic impairments
US6696495B2 (en) 1998-12-02 2004-02-24 Snowden Pharmaceuticals, Llc Treatment of disorders secondary to organic impairments
US6552087B1 (en) 1999-03-19 2003-04-22 Abbott Gmbh & Co. Kg Therapeutic agent comprising (+)-sibutramine
US6723717B1 (en) 1999-06-01 2004-04-20 The University Of Texas Southwestern Medical Center Sulfur-containing thyroxane derivatives and their use as hair growth promotors
US6680344B1 (en) 1999-06-01 2004-01-20 The University Of Texas Southwestern Medical Center Method of treating hair loss using diphenylmethane derivatives
MXPA01012494A (es) 1999-06-01 2002-07-02 Univ Texas Southwestern Med Ct Metodo para tratar perdida capilar con el uso de compuestos sulfonil tiromimeticos.
GB9914744D0 (en) * 1999-06-24 1999-08-25 Knoll Ag Therapeutic agents
US6399826B1 (en) 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
WO2002083631A1 (en) * 2001-04-13 2002-10-24 Sepracor Inc. Methods of preparing didesmethylsibutramine and other sibutramine derivatives
PL376577A1 (pl) 2002-06-17 2006-01-09 Themis Laboratories Private Limited Wielowarstwowe tabletki zawierające tiazolidinedion i biguanidy oraz metody ich wytwarzania
MXPA05003355A (es) * 2002-10-05 2005-10-18 Hanmi Pharm Ind Co Ltd Composicion farmaceutica que comprende semihidrato de metansulfonato de sibutramina cristalino.
US20050131074A1 (en) * 2003-08-04 2005-06-16 Beckman Kristen M. Methods for treating metabolic syndrome
AR045330A1 (es) * 2003-08-07 2005-10-26 Sb Pharmco Inc Forma de dosificacion oral, procedimiento para su preparacion y uso del compuesto 5-(4-(2-(n-metil-n- (2-piridil)amino)etoxi )bencil) tiazolidin-2,4-diona o una sal o solvato farmaceuticamente aceptable del mismo para prepararla
GB0318824D0 (en) * 2003-08-11 2003-09-10 Glaxo Group Ltd Novel composition
TWI339586B (en) * 2003-10-31 2011-04-01 Takeda Chemical Industries Ltd Solid preparation comprising pioglitazone or salt thereof,glimpiride and polyoxyethylene sorbitan fatty acid ester
KR100627687B1 (ko) * 2005-04-20 2006-09-25 주식회사 씨티씨바이오 시부트라민 유리염기 함유 조성물 및 이의 제조방법
MX2009002781A (es) 2006-09-15 2009-03-30 Reviva Pharmaceuticals Inc Sintesis, metodos de uso y composiciones de cicloalquilmetilaminas .
KR100812538B1 (ko) * 2006-10-23 2008-03-11 한올제약주식회사 약물 제어방출형 메트포르민-글리메피리드 복합제제
BRPI0716002A2 (pt) * 2006-11-22 2013-07-30 Sk Chemicals Co Ltd complexo de inclusço, processo de preparaÇço de um complexo de inclusço e composiÇço de tratamento e prevenÇço de hipocondria e obesidade
US8889632B2 (en) 2007-01-31 2014-11-18 Dana-Farber Cancer Institute, Inc. Stabilized p53 peptides and uses thereof
EP2508531B1 (en) 2007-03-28 2016-10-19 President and Fellows of Harvard College Stitched polypeptides
WO2011003039A2 (en) 2009-07-02 2011-01-06 Dexcom, Inc. Analyte sensors and methods of manufacturing same
WO2012003501A2 (en) 2010-07-02 2012-01-05 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
SI2603600T1 (sl) 2010-08-13 2019-04-30 Aileron Therapeutics, Inc. Peptidomimetični makrocikli
TW201806968A (zh) 2011-10-18 2018-03-01 艾利倫治療公司 擬肽巨環化合物
IN2014MN01407A (cg-RX-API-DMAC10.html) 2011-12-30 2015-07-03 Reviva Pharmaceuticals Inc
KR102112373B1 (ko) 2012-02-15 2020-05-18 에일러론 테라퓨틱스 인코포레이티드 펩티드모방체 마크로사이클
HK1205454A1 (en) 2012-02-15 2015-12-18 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
WO2014071241A1 (en) 2012-11-01 2014-05-08 Aileron Therapeutics, Inc. Disubstituted amino acids and methods of preparation and use thereof
BR112017005598A2 (pt) 2014-09-24 2017-12-12 Aileron Therapeutics Inc macrociclos peptidomiméticos e usos dos mesmos
WO2016154058A1 (en) 2015-03-20 2016-09-29 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2098602B (en) * 1981-04-06 1984-08-22 Boots Co Plc Therapeutic agents

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
GB8704777D0 (en) * 1987-02-28 1987-04-01 Boots Co Plc Medical treatment
JP2675573B2 (ja) * 1988-03-31 1997-11-12 科研製薬株式会社 脳機能改善剤
IE61928B1 (en) * 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity
WO1995010292A1 (en) 1993-10-14 1995-04-20 Biomedica California, Inc. Diabetes treatment and prophylaxis
US5459164A (en) 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment
GB9619757D0 (en) * 1996-09-21 1996-11-06 Knoll Ag Chemical process

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2098602B (en) * 1981-04-06 1984-08-22 Boots Co Plc Therapeutic agents

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ЛОУРЕНС Д.Р. и др. Клиническая фармакология. Т.2. - М.: Медицина, 1993, с.577-587. *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2430913C2 (ru) * 2006-01-06 2011-10-10 Сепракор Инк. Циклоалкиламины в качестве ингибиторов повторного поглощения моноамина
RU2832377C1 (ru) * 2024-01-09 2024-12-23 Владимир Анатольевич Пуценко Способ первичной профилактики сахарного диабета первого типа с применением внутритканевого электрофореза поджелудочной железы с профилактическими препаратами

Also Published As

Publication number Publication date
HUP9904026A2 (hu) 2000-05-28
HRP970505A2 (en) 1998-08-31
BR9711517A (pt) 1999-08-24
KR20000048501A (ko) 2000-07-25
TR199900618T2 (xx) 1999-06-21
PL332305A1 (en) 1999-08-30
BG64473B1 (bg) 2005-04-30
US6174925B1 (en) 2001-01-16
IL128850A0 (en) 2000-01-31
HUP9904026A3 (en) 2000-07-28
NO991358D0 (no) 1999-03-19
US6617360B1 (en) 2003-09-09
MY116150A (en) 2003-11-28
AU724488B2 (en) 2000-09-21
CA2266401C (en) 2007-01-30
ID18320A (id) 1998-03-26
GB9619757D0 (en) 1996-11-06
NO991358L (no) 1999-03-19
NZ334580A (en) 2000-09-29
US20040077730A1 (en) 2004-04-22
UA64726C2 (uk) 2004-03-15
CA2266401A1 (en) 1998-03-26
TW580385B (en) 2004-03-21
SK31999A3 (en) 1999-12-10
BG103277A (en) 2000-01-31
ZA978450B (en) 1999-03-19
JP2001503737A (ja) 2001-03-21
EP0927028A1 (en) 1999-07-07
WO1998011884A1 (en) 1998-03-26
IL128850A (en) 2003-07-31
AU4774097A (en) 1998-04-14
CZ93699A3 (cs) 1999-08-11
CN1237905A (zh) 1999-12-08

Similar Documents

Publication Publication Date Title
US6617360B1 (en) Medical treatment
KR100339874B1 (ko) 글루코오스 내성을 개선하기 위한 제약 조성물
EP0973511B1 (en) Use of sibutramine analogues to lower lipid levels
US20030130355A1 (en) Therapeutic agents
EP1039900B1 (en) Pharmaceutical composition containing sibutramine and orlistat
US6376552B1 (en) Treatment of gallstones
RU2229289C2 (ru) Фармацевтическая композиция, содержащая сибутрамин и орлистат
CN112022862B (zh) 磺酰脲类药物的抗衰老新用途
JP2004513962A (ja) 抗糖尿病作用を有する新規な薬剤組成物およびその製剤方法
MXPA99002598A (en) Use of sibutramine analogues to prevent the development of diabetes
RU2234917C2 (ru) Терапевтические средства
MXPA01007388A (es) Metodo para ayudar a dejar de fumar.
MXPA00006201A (en) Pharmaceutical composition containing sibutramine and orlistat
CA2368416A1 (en) Treatment of gallstones

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20080916